Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
Clinical trial NCT00514696 · COMPLETED
Trial details
- NCT number
- NCT00514696
- Sponsor
- La Jolla Pharmaceutical Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2009-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.